Triton Therapeutics, Inc.
PrivateLast Round
Seed
Oct 17, 2025
Total Funding Raised
$36.36M
Company Overview
Triton Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Stamford, Connecticut. Its latest recorded funding round was a Seed round in October 2025.
Triton Therapeutics, Inc. is a biotechnology company that develops first-in-class medicines targeting autoimmune and fibrotic diseases by addressing underlying disease pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triton Therapeutics, Inc. Comparables
Compare Triton Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mirador Therapeutics | 80% | |
| COUR Pharmaceuticals | 80% | |
| AltruBio | 79% |
For institutional investors. Book with your work email.
Triton Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Triton Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canaan Partners | Seed |
| Cure Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 17, 2025
$36.4M raised with participation from Canaan Partners and Cure Ventures.
For institutional investors. Book with your work email.
Triton Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Triton Therapeutics, Inc.'s valuation, stock price, and market status.
Is Triton Therapeutics, Inc. a public or private company?
Triton Therapeutics, Inc. is a private company.
What is the current stock price of Triton Therapeutics, Inc.?
Triton Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Triton Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Triton Therapeutics, Inc. worth (valuation)?
Valuation information for Triton Therapeutics, Inc. is not publicly available.
Can I buy Triton Therapeutics, Inc. stock?
Triton Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Triton Therapeutics, Inc.'s last funding round?
Triton Therapeutics, Inc.'s most recent funding round was Seed on October 17, 2025.
Who are the main investors in Triton Therapeutics, Inc.?
Key investors in Triton Therapeutics, Inc. include Canaan Partners, Cure Ventures.
Will Triton Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Triton Therapeutics, Inc..
How can I track Triton Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Triton Therapeutics, Inc.'s shares on secondary markets.